Page 2 - Amphastar Nanjing Pharmaceuticals Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amphastar nanjing pharmaceuticals ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amphastar Nanjing Pharmaceuticals Ltd Today - Breaking & Trending Today

Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg

RANCHO CUCAMONGA, CA / ACCESSWIRE / March 8, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") announced that the U.S. Food and Drug Administration ("FDA") has granted ....

Dennis Riedl , Jack Zhang , Exchange Commission , Company Information , Most Of The Company , Amphastar Pharmaceuticals Inc , Drug Administration , Amphastar Pharmaceuticals Inc View , Amphastar Pharmaceuticals , New Drug Application , Chief Executive Officer , Master Files , Annual Report , Inc View ,

Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2022

Reports Net Revenues of $135.0 Million for the Three Months Ended December 31, 2022RANCHO CUCAMONGA, CA / ACCESSWIRE / February 28, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or ....

Dennis Riedl , Jack Zhang , Co Ltd , Company Information , Most Of The Company , Amphastar Pharmaceuticals Inc , Exchange Commission , Hanxin Pharmaceutical Technology Co Ltd , Amphastar Pharmaceuticals Inc View , Reports Net Revenues , Three Months Ended December , Amphastar Pharmaceuticals , Chief Executive Officer , Ended December , Amphastar Nanjing Pharmaceutical , Master Files , Annual Report , Quarterly Report , Consolidated Statement , Months Ended December , Inc View ,

Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2023

RANCHO CUCAMONGA, CA / ACCESSWIRE / February 22, 2023 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its fourth quarter of 2022 ended December 31, 2022 ....

Dennis Riedl , Exchange Commission , Company Information , Most Of The Company , Amphastar Pharmaceuticals Inc , Amphastar Pharmaceuticals Inc View , Amphastar Pharmaceuticals , Annual Report , Quarterly Report , Inc View ,

Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark

/PRNewswire/ Phastar announced today the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR. ....

City Of , United Kingdom , Scott Mcgregor , Phastar Phizual , Prnewswire Phastar , Andrew Macgarvey , S Cubed Aps , New Year , Managing Directors Cubed , Best Companies ,

Amphastar Pharmaceuticals, Inc.: Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESSWIRE / November 22, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Tony Marrs, Sr. Vice President Regulatory Affairs and Clinical ....

Piper Sandler , Exchange Commission , Amphastar Pharmaceuticals , Regulatory Affairs , Most Of The Company , Amphastar Pharmaceuticals Inc , Amphastar Pharmaceuticals Inc View , Bill Peters , Tony Marrs , Vice President Regulatory Affairs , Clinical Operations , Annual Healthcare Conference , Amphastar Pharmaceutical , Annual Report , Quarterly Report , Inc View ,